These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 36197397)
21. Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults. Sanford M; Keating GM Drugs Aging; 2010 Feb; 27(2):159-76. PubMed ID: 20104941 [TBL] [Abstract][Full Text] [Related]
22. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376 [TBL] [Abstract][Full Text] [Related]
23. Herpes zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination. Almutairi N; Almutairi AN; Almazyad M; Alwazzan S Dermatol Ther; 2022 Jul; 35(7):e15521. PubMed ID: 35434963 [TBL] [Abstract][Full Text] [Related]
25. Varicella zoster vaccines and their implications for development of HSV vaccines. Gershon AA Virology; 2013 Jan; 435(1):29-36. PubMed ID: 23217613 [TBL] [Abstract][Full Text] [Related]
26. Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report. Miller C; Taylor-Salmon E; Emuren L; Landry M; Gershon A; Miller G BMC Infect Dis; 2023 Dec; 23(1):854. PubMed ID: 38057696 [TBL] [Abstract][Full Text] [Related]
28. Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study. Lal H; Poder A; Campora L; Geeraerts B; Oostvogels L; Vanden Abeele C; Heineman TC Vaccine; 2018 Jan; 36(1):148-154. PubMed ID: 29174683 [TBL] [Abstract][Full Text] [Related]
29. A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su. Strezova A; Godeaux O; Aggarwal N; Leroux-Roels G; Lopez-Fauqued M; Van Damme P; Vanden Abeele C; Vastiau I; Heineman TC; Lal H Vaccine; 2017 Dec; 35(48 Pt B):6700-6706. PubMed ID: 29079101 [TBL] [Abstract][Full Text] [Related]
30. Safety, and Humoral and Cell-mediated Immune Responses to Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis. Koh JH; Lee J; Kim SH; Kwok SK; Ju JH; Park SH J Rheumatol; 2018 Apr; 45(4):465-469. PubMed ID: 29419465 [TBL] [Abstract][Full Text] [Related]
31. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013. Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754 [TBL] [Abstract][Full Text] [Related]
32. Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report. Medhat R; El Lababidi R; Abdelsalam M; Nusair A Int J Infect Dis; 2022 Jun; 119():184-186. PubMed ID: 35398296 [TBL] [Abstract][Full Text] [Related]
33. Effect of the varicella vaccination implementation on the development of herpes zoster in children and adolescents. Inan Yuksel E; Kara Polat A; Gore Karaali M; Koku Aksu AE; Gurel MS Dermatol Ther; 2021 Jul; 34(4):e14995. PubMed ID: 34031954 [TBL] [Abstract][Full Text] [Related]
34. Tale of two vaccines: differences in response to herpes zoster vaccines. Gershon AA J Clin Invest; 2018 Oct; 128(10):4245-4247. PubMed ID: 30179221 [TBL] [Abstract][Full Text] [Related]
35. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400 [TBL] [Abstract][Full Text] [Related]
36. Effect of Routine Varicella Immunization on the Epidemiology and Immunogenicity of Varicella and Shingles. Otani N; Shima M; Yamamoto T; Okuno T Viruses; 2022 Mar; 14(3):. PubMed ID: 35336994 [TBL] [Abstract][Full Text] [Related]